2013年12月6日星期五

The Turning Point for My Son’s Life

Name: Xiao Bo
Gender: boy
Age: 3

Unbelievably, most of Xiao Bo’s symptoms are improved by stem cell treatment for cerebral palsy, his parents was so excited and promised to make the second course of treatment, because they’ve found the cure for Xiao Bo.

Xiao Bo is 3 years old, but he had been affected with “lalopathy (speech dysfunction) and motor retardation” for 2 years. The boy was the first twin in premature birth of only 29 weeks plus 3 days. He had only 1.3 kg after birth. Due to postpartum anoxia, he was suffered from cerebral palsy (diagnosed as spasm type).
When he first came to our center in April, 18th, 2011, he appeared so soft that he couldn’t even stand and sit well, because he had no strength in his limbs and waist. He was incapable of creeping forward with his hands and legs. When he sat there, he seemed a bow due to lack of strength in his waist. He couldn’t stand even leaning against the wall. Only with the help of other people, he could stand. Besides, he couldn’t raise his two hands at the same time.
In the following 20 days, we made him the first course of stem cell treatment for cerebral palsy. We observed that he responsed well to the stem cells and improved rapidly.
The follow-up survey of 10 months after his treatment showed that he could creep normally and sit steadily as other child due to the increased strength in his waist. He never seemed a bow when sitting. Besides, he could stand leaning against the wall without any extra support, and he could use his hands freely.

Seeing these surprised improvements, Xiao Bo’s parents are so happy and grateful, the promised that they will take him receive the second course of stem cell treatment for cerebral palsy. He is still young who response well to stem cells, so they should guarantee a better future for their son. They believe it’s the turning point for his life.

Before stem cell treatment, he couldn't stand leaning against the wall
After  stem cell treatment, he could sit steadily

没有评论:

发表评论